Literature DB >> 26899987

Differential Effects of Antiepileptic Drugs on Focal Seizures in the Intrahippocampal Kainate Mouse Model of Mesial Temporal Lobe Epilepsy.

Venceslas Duveau1, Benoît Pouyatos1, Karine Bressand1, Céline Bouyssières1, Tanguy Chabrol2,3, Yann Roche1, Antoine Depaulis2,3,4, Corinne Roucard1.   

Abstract

AIMS: Mesial temporal lobe epilepsy (MTLE) is the most common form of drug-refractory epilepsy. Most of the morphological and electrophysiological features of human MTLE can be reproduced in a mouse by a unilateral intrahippocampal injection of kainate (MTLE mouse model). The effects of antiepileptic drugs (AEDs) on the occurrence of recurrent focal hippocampal seizures in this model remain to be specified. Here, we addressed the pharmacological reactivity of this model to the most commonly used AEDs.
METHODS: Using depth electroencephalographical (EEG) recordings, we tested the dose-response effects of acute injection of nine AEDs on the occurrence of hippocampal paroxysmal discharges (HPDs) as well as on ictal and interictal power spectra in the MTLE mouse model.
RESULTS: Valproate, carbamazepine, and lamotrigine dose dependently suppressed HPDs and modified the general behavior and/or EEG activity. Levetiracetam and pregabalin suppressed HPDs at high doses but without any behavioral nor interictal EEG changes. Finally, phenobarbital, tiagabine, vigabatrin, and diazepam suppressed HPDs in a dose-dependent manner at doses devoid of obvious behavioral effects.
CONCLUSION: The MTLE mouse model displays a differential sensitivity to AEDs with a greater efficacy of drug that facilitates GABAergic transmission. This model provides an efficient tool to identify new treatment for drug-resistant forms of focal epilepsies.
© 2016 John Wiley & Sons Ltd.

Entities:  

Keywords:  Animal model; EEG; Fast Fourier transform; Focal paroxysmal discharge; Hippocampus; Quantitative EEG

Mesh:

Substances:

Year:  2016        PMID: 26899987      PMCID: PMC6492802          DOI: 10.1111/cns.12523

Source DB:  PubMed          Journal:  CNS Neurosci Ther        ISSN: 1755-5930            Impact factor:   5.243


  30 in total

1.  Pharmacological characterization of the 6 Hz psychomotor seizure model of partial epilepsy.

Authors:  M E Barton; B D Klein; H H Wolf; H S White
Journal:  Epilepsy Res       Date:  2001-12       Impact factor: 3.045

2.  Therapy discovery for pharmacoresistant epilepsy and for disease-modifying therapeutics: summary of the NIH/NINDS/AES models II workshop.

Authors:  James P Stables; Ed Bertram; F E Dudek; Greg Holmes; Gary Mathern; Asla Pitkanen; H S White
Journal:  Epilepsia       Date:  2003-12       Impact factor: 5.864

3.  Activity profile of pregabalin in rodent models of epilepsy and ataxia.

Authors:  Mark G Vartanian; Louis L Radulovic; Jack J Kinsora; Kevin A Serpa; Marguerite Vergnes; Edward Bertram; Charles P Taylor
Journal:  Epilepsy Res       Date:  2005-12-05       Impact factor: 3.045

4.  On the origin of interictal activity in human temporal lobe epilepsy in vitro.

Authors:  Ivan Cohen; Vincent Navarro; Stéphane Clemenceau; Michel Baulac; Richard Miles
Journal:  Science       Date:  2002-11-15       Impact factor: 47.728

5.  Quantitative EEG effects of carbamazepine, oxcarbazepine, valproate, lamotrigine, and possible clinical relevance of the findings.

Authors:  Béla Clemens; Andrea Ménes; Pálma Piros; Mónika Bessenyei; Anna Altmann; Judit Jerney; Katalin Kollár; Beáta Rosdy; Margit Rózsavölgyi; Katalin Steinecker; Katalin Hollódy
Journal:  Epilepsy Res       Date:  2006-06-09       Impact factor: 3.045

6.  Evolution of hippocampal epileptic activity during the development of hippocampal sclerosis in a mouse model of temporal lobe epilepsy.

Authors:  V Riban; V Bouilleret; B T Pham-Lê; J-M Fritschy; C Marescaux; A Depaulis
Journal:  Neuroscience       Date:  2002       Impact factor: 3.590

7.  The temporopolar cortex plays a pivotal role in temporal lobe seizures.

Authors:  Stéphan Chabardès; Philippe Kahane; Lorella Minotti; Laura Tassi; Sylvie Grand; Dominique Hoffmann; Alim Louis Benabid
Journal:  Brain       Date:  2005-04-27       Impact factor: 13.501

8.  Lamotrigine pharmacokinetic/pharmacodynamic modelling in rats.

Authors:  M M Castel-Branco; A C Falcão; I V Figueiredo; M M Caramona
Journal:  Fundam Clin Pharmacol       Date:  2005-12       Impact factor: 2.748

9.  Seizure suppression by adenosine A1 receptor activation in a mouse model of pharmacoresistant epilepsy.

Authors:  Nicolette Gouder; Jean-Marc Fritschy; Detlev Boison
Journal:  Epilepsia       Date:  2003-07       Impact factor: 5.864

10.  An electro-encephalogram beta gap after induction with diazepam: a localization method in epileptogenic lesions.

Authors:  Steven Claus; Frans Leijten; Paul Kallansee; John Klepper; Fernando H Lopes da Silva; Hanneke Ronner; Demetrios Velis; Max A Viergever; Stiliyan Kalitzin
Journal:  Clin Neurophysiol       Date:  2009-05-22       Impact factor: 3.708

View more
  25 in total

1.  Hepatic and hippocampal cytochrome P450 enzyme overexpression during spontaneous recurrent seizures.

Authors:  Leonie Runtz; Benoit Girard; Marion Toussenot; Julie Espallergues; Alexis Fayd'Herbe De Maudave; Alexandre Milman; Frederic deBock; Chaitali Ghosh; Nathalie C Guérineau; Jean-Marc Pascussi; Federica Bertaso; Nicola Marchi
Journal:  Epilepsia       Date:  2017-11-10       Impact factor: 5.864

Review 2.  A Mesiotemporal Lobe Epilepsy Mouse Model.

Authors:  Duveau Venceslas; Roucard Corinne
Journal:  Neurochem Res       Date:  2017-03-23       Impact factor: 3.996

3.  Evaluation of Cannabidiol in Animal Seizure Models by the Epilepsy Therapy Screening Program (ETSP).

Authors:  Brian D Klein; Catherine A Jacobson; Cameron S Metcalf; Misty D Smith; Karen S Wilcox; Aidan J Hampson; John H Kehne
Journal:  Neurochem Res       Date:  2017-05-06       Impact factor: 3.996

Review 4.  Animal Models of Seizures and Epilepsy: Past, Present, and Future Role for the Discovery of Antiseizure Drugs.

Authors:  Wolfgang Löscher
Journal:  Neurochem Res       Date:  2017-03-13       Impact factor: 3.996

5.  Validation of a Preclinical Drug Screening Platform for Pharmacoresistant Epilepsy.

Authors:  Melissa L Barker-Haliski; Kristina Johnson; Peggy Billingsley; Jennifer Huff; Laura J Handy; Rizvana Khaleel; Zhenmei Lu; Matthew J Mau; Timothy H Pruess; Carlos Rueda; Gerald Saunders; Tristan K Underwood; Fabiola Vanegas; Misty D Smith; Peter J West; Karen S Wilcox
Journal:  Neurochem Res       Date:  2017-03-16       Impact factor: 3.996

6.  Pharmacoresponsiveness of spontaneous recurrent seizures and the comorbid sleep disorder of epileptic Kcna1-null mice.

Authors:  Malavika Deodhar; Stephanie A Matthews; Brittany Thomas; Leena Adamian; Sarah Mattes; Tabitha Wells; Brianna Zieba; Kristina A Simeone; Timothy A Simeone
Journal:  Eur J Pharmacol       Date:  2021-11-25       Impact factor: 4.432

Review 7.  The Search for New Screening Models of Pharmacoresistant Epilepsy: Is Induction of Acute Seizures in Epileptic Rodents a Suitable Approach?

Authors:  Wolfgang Löscher
Journal:  Neurochem Res       Date:  2016-08-08       Impact factor: 3.996

Review 8.  Drug Resistance in Epilepsy: Clinical Impact, Potential Mechanisms, and New Innovative Treatment Options.

Authors:  Wolfgang Löscher; Heidrun Potschka; Sanjay M Sisodiya; Annamaria Vezzani
Journal:  Pharmacol Rev       Date:  2020-07       Impact factor: 25.468

9.  Medial septal GABAergic neurons reduce seizure duration upon optogenetic closed-loop stimulation.

Authors:  Katerina Hristova; Cristina Martinez-Gonzalez; Thomas C Watson; Neela K Codadu; Kevan Hashemi; Peter C Kind; Matthew F Nolan; Alfredo Gonzalez-Sulser
Journal:  Brain       Date:  2021-06-22       Impact factor: 15.255

Review 10.  The current approach of the Epilepsy Therapy Screening Program contract site for identifying improved therapies for the treatment of pharmacoresistant seizures in epilepsy.

Authors:  Karen S Wilcox; Peter J West; Cameron S Metcalf
Journal:  Neuropharmacology       Date:  2019-11-30       Impact factor: 5.273

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.